A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction
Introduction
Morphine, a drug derived from the natural juice of the opium poppy, is considered to be the most potent analgesic painkiller available, in addition, the drug is known to induce relaxation and euphoria. Given these properties, all opioids, including morphine, heroin, and prescription analgesics, such as Vicodin and OxyContin, have extremely high abuse potential. Dependence on these drugs is associated with a multitude of health and social problems, such as increased risk for HIV, mortality, crime, unemployment, legal issues, and interpersonal breakdowns (Haug, Sorensen, Gruber, & Song, 2005). For these reasons, opioid addiction, has been termed a “chronic, relapsing disease,” (Leshner, 1998a) and presents a substantial public health concern.
Although typically the territory of psychiatry or substance-specific intervention centers, it is important that researchers and practicing psychologists understand and appreciate the mechanisms of opioid addiction and are knowledgeable about available treatment options. As rates of prescription opioid use continue to climb (McCabe, Cranford, & West, 2008), clinicians are considerably more likely to encounter opioid abusers in their practice. Fortunately, research on treatment of opioid abuse and dependence is plentiful, perhaps to the point of being overwhelming; a brief search of PsychInfo using the terms ‘opioid’ or ‘heroin’ combined with ‘treatment’ yields over 18,000 articles in peer-reviewed journals. The majority of this research has focused on the development and effectiveness of pharmacological treatments (e.g., methadone), with a comparative dearth of studies on psychosocial treatment regimens or components. Considering the half-life of scientific knowledge and rapid advances in treatments for opioid dependence, the current review aims to synthesize to the current status of opioid dependence treatment.
Section snippets
Epidemiology
Worldwide, the annual prevalence of opioid use among persons aged 15–64 has remained relatively stable at 0.4% for the past decade (United Nations Office on Drugs & Crime, 2008). However, lifetime prevalence rates indicate that 1.7% of people aged 19–30 have tried heroin, and a staggering 18.7% have used other opioids, with Vicodin and OxyContin the two most popular opioid prescription drugs (Johnston, O'Malley, Bachman, & Schulenberg, 2008b). Indeed, non-medical prescription opioid use is on
Pharmacological treatment options
As mentioned previously, treatment of opioid dependence typically includes a pharmacological option. After reviewing the neural mechanism of opioids, we will discuss the three major classes of pharmacological treatments for opioid dependence: opioid agonists, opioid antagonists, and drugs that do not work directly on the opioid receptors.
Efficacy of treatment strategies
Our goals for presenting efficacy research below are two-fold. First, we wish to provide an up-to-date review of efficacious opioid treatment across all treatment strategies. We first turned to the Cochrane reviews (Cochrane Collection, 2009) on treatment for opioid dependence, as these systematic reviews provide a rigorous examination of well-designed studies (e.g., randomized controlled trials, controlled prospective studies) using meta-analytic techniques whenever possible. Although there
Crisis management
Fatal overdoses are one of the most common causes of death for heroin addicts (van de Brink & Haasen, 2006), and non-fatal overdoses due to opioids seem to be increasing; from 2004 to 2005, hospital visits due to opioids increased by 24% (SAMHSA, 2005). The first line of treatment for overdose is the short-acting opioid antagonist naloxone (Darke and Hall, 2003, van de Brink and Haasen, 2006). Naloxone, which has no effect on non-opioid dependent individuals and has no abuse potential, is
Summary and conclusions
Opioids have been used and abused for hundreds of years. In recent years, research on the treatment of opioid dependence has flourished and many treatment options are available. Active research programs now extend from animal models to large-scale clinical trials, many of which are focused on evaluation of both longstanding and newer treatments. Several points, gleaned from the above review, are worthy of additional mention.
References (121)
- et al.
Effectiveness of interventions on opiate withdrawal treatment: An overview of systematic reviews
Drug and Alcohol Dependence
(2004) - et al.
An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research
Journal of Substance Abuse Treatment
(2005) - et al.
Targeting HIV-related outcomes with intravenous drug users maintained on methadone: A randomized clinical trial of a harm reduction group therapy
Journal of Substance Abuse Treatment
(2004) - et al.
The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients
Drug and Alcohol Dependence
(2001) - et al.
Slow tapering from methadone maintenance in a program encouraging indefinite maintenance
Journal of Substance Abuse Treatment
(2006) Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes
Addictive Behaviors
(1997)- et al.
Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs
Brain Research Reviews
(2008) - et al.
Polydrug dependence and psychiatric comorbidity among heroin injectors
Drug and Alcohol Dependence
(1997) - et al.
Psychopathology and HIV risk behaviors among injection drug users in and out of treatment
Drug and Alcohol Dependence
(1996) - et al.
Retention rate and illicit opioid use during methadone maintenance interventions: A meta-analysis
Drug and Alcohol Dependence
(2002)
Consensus statement on office-based treatment of opioid dependence using buprenorphine
Journal of Substance Abuse Treatment
Women who abuse prescription opioids: Findings from the Addiction Severity Index-Multimedia version Connect prescription opioid database
Drug and Alcohol Dependence
Contingency management in outpatient methadone treatment: A meta-analysis
Drug and Alcohol Dependence
The role of personality disorders on drug dependence treatment outcomes following inpatient detoxification
European Psychiatry
Differential involvement of endogenous opioids in sucrose consumption and food reinforcement
Pharmacology, Biochemistry and Behavior
Addiction to opioids in chronic pain patients: A literature review
European Journal of Pain
Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: A study from Lebanon
Comprehensive Psychiatry
Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia
Journal of Substance Abuse Treatment
Drug addiction research: Moving toward the 21st century
Drug and Alcohol Dependence
Recent advances in the treatment of opiate addiction
Clinical Neuroscience Research
The economic costs of heroin addiction in the United States
Drug and Alcohol Dependence
Are detoxification programmes effective?
Lancet
Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders and treatment utilization: Results from two national surveys
Addictive Behaviors
Blood naltrexone levels over time following naltrexone implant
Progress in Neuro-Psychopharmacology & Biological Psychiatry
Long-term opioid therapy for chronic noncancer pain: A systematic review and meta-analysis of efficacy and safety
Journal of Pain and Symptom Management
Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine
Addictive Behaviors
A randomized, controlled trial of low dose naltrexone for the treatment of opioid dependence
Drug and Alcohol Dependence
Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: A randomized, double-blind, placebo-controlled trial
Lancet
Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine
Biological Psychiatry
Brief buprenorphine detoxification for the treatment of prescription opioid dependence: A pilot study
Addictive Behaviors
Prescription naloxone: A novel approach to heroin overdose prevention
Annals of Emergency Medicine
Methadone at tapered doses for the management of opioid withdrawal
Cochrane Database of Systematic Reviews (Online)
Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification
Cochrane Database of Systematic Reviews (Online)
Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence
Cochrane Database of Systematic Reviews (Online)
Levo-alpha-acetylmethadol (LAAM) versus methadone maintenance: 1-year treatment retention, outcomes and status
Addiction
Longitudinal effects of LAAM and methadone maintenance on heroin addict behavior
Journal of Behavioral Health Services & Research
Take-home naloxone to reduce heroin death
Addiction
Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users
Addiction
Psychiatric and substance use comorbidity among treatment-seeking opioid abusers
Archives of General Psychiatry
Experimental heat pain for detecting pregnancy-induced analgesia in humans
International Aneshesia Research Society
Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials
American Journal of Drug and Alcohol Abuse
LAAM maintenance vs methadone maintenance for heroin dependence
Cochrane Database of Systematic Reviews
Injectable, sustained-release naltrexone for the treatment of opioid dependence
Archives of General Psychiatry
Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation
Health Technology Assessment (Winchester, England)
Heroin overdose: Research and evidence-based intervention
Journal of Urban Health: Bulletin of the New York Academy of Medicine
Long run abstinence after narcotics abuse: What are the odds?
Management Science
Medication-free treatment of opioid dependence
Positive reinforcement theories of addiction
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats
Proceedings of the National Academy of Sciences
Cited by (247)
Trajectories of drug treatment and illicit opioid use in the AIDS Linked to the IntraVenous Experience cohort, 2014–2019
2023, International Journal of Drug PolicyMachine-learning analysis of opioid use disorder informed by MOR, DOR, KOR, NOR and ZOR-based interactome networks
2023, Computers in Biology and MedicineImpact of social media-based intervention in reducing youths’ propensity to engage in drug abuse in Nigeria
2022, Evaluation and Program PlanningA Qualitative Inquiry into the Challenges in Overcoming Heroin Addiction Among Chinese Individuals Who Experience Voluntary Rehabilitation
2024, Journal of Psychoactive DrugsA Follow-up Study on Coping Strategies and its Association with Relapse Among Alcohol-dependent Patients
2024, Indian Journal of Psychological MedicineWhen a pandemic and epidemic collide: Lessons learned about how system barriers can interrupt implementation of addiction research
2023, Implementation Research and Practice